The Livforsakringsbolaget Skandia Omsesidigt Sells 3,951 Shares of Clorox Company (The) (CLX)

The Livforsakringsbolaget Skandia Omsesidigt Sells 3,951 Shares of Clorox Company (The) (CLX)

Livforsakringsbolaget Skandia Omsesidigt decreased its position in shares of Clorox Company (The) (NYSE:CLX) by 40.5% during the third quarter, Holdings Channel reports. The fund owned 5,800 shares of the company’s stock after selling 3,951 shares during the period. Livforsakringsbolaget Skandia Omsesidigt’s holdings in Clorox Company (The) were worth $494,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Bank of Montreal Can acquired a new stake in Clorox Company (The) during the second quarter worth about $53,902,000. BlackRock Institutional Trust Company N.A. increased its stake in shares of Clorox Company (The) by 8.6% in the second quarter. BlackRock Institutional Trust Company N.A. now owns 4,890,145 shares of the company’s stock valued at $676,747,000 after buying an additional 385,723 shares in the last quarter. Janus Capital Management LLC increased its stake in shares of Clorox Company (The) by 17.1% in the second quarter. Janus Capital Management LLC now owns 1,989,769 shares of the company’s stock valued at $275,364,000 after buying an additional 290,125 shares in the last quarter. BlackRock Inc. increased its stake in shares of Clorox Company (The) by 38.9% in the second quarter. BlackRock Inc. now owns 891,759 shares of the company’s stock valued at $123,411,000 after buying an additional 249,691 shares in the last quarter. Finally, BlackRock Fund Advisors increased its stake in shares of Clorox Company (The) by 8.2% in the second quarter. BlackRock Fund Advisors now owns 3,275,427 shares of the company’s stock valued at $453,286,000 after buying an additional 248,436 shares in the last quarter. 69.44% of the stock is currently owned by institutional investors.

Clorox Company (NYSE:CLX) traded down 0.34% during mid-day trading on Wednesday, hitting $120.91. 701,248 shares of the company’s stock traded hands. Clorox Company has a one year low of $111.24 and a one year high of $140.47. The firm’s 50-day moving average price is $118.55 and its 200-day moving average price is $124.14. The stock has a market cap of $15.57 billion, a PE ratio of 24.34 and a beta of 0.33.

Clorox Company (The) (NYSE:CLX) last released its earnings results on Wednesday, November 2nd. The company reported $1.36 earnings per share for the quarter, missing the consensus estimate of $1.42 by $0.06. The firm earned $1.44 billion during the quarter, compared to analyst estimates of $1.24 billion. Clorox Company (The) had a net margin of 11.27% and a return on equity of 250.82%. The business’s revenue was up 3.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.32 earnings per share. On average, analysts forecast that Clorox Company will post $5.33 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, February 10th. Shareholders of record on Wednesday, January 25th will be given a $0.80 dividend. This represents a $3.20 annualized dividend and a yield of 2.65%. The ex-dividend date is Monday, January 23rd. Clorox Company (The)’s dividend payout ratio is currently 64.26%.

Several brokerages have recently weighed in on CLX. Zacks Investment Research downgraded shares of Clorox Company (The) from a “buy” rating to a “hold” rating in a research note on Tuesday, October 4th. Barclays PLC raised shares of Clorox Company (The) from an “underweight” rating to an “equal weight” rating and reduced their target price for the company from $115.00 to $111.00 in a research note on Monday, January 9th. Morgan Stanley raised shares of Clorox Company (The) from an “underweight” rating to an “equal weight” rating and set a $112.00 target price on the stock in a research note on Friday, December 16th. They noted that the move was a valuation call. B. Riley reissued a “neutral” rating and issued a $123.00 target price on shares of Clorox Company (The) in a research note on Wednesday, November 30th. Finally, BMO Capital Markets assumed coverage on shares of Clorox Company (The) in a research note on Thursday, December 15th. They issued an “outperform” rating and a $136.00 target price on the stock. One investment analyst has rated the stock with a sell rating, twelve have issued a hold rating and two have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $126.75.

In other news, Director A D. David Mackay bought 5,000 shares of the company’s stock in a transaction on Thursday, December 1st. The stock was bought at an average cost of $114.90 per share, with a total value of $574,500.00. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. 0.74% of the stock is owned by company insiders.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Related posts

Leave a Comment